Baby Cereals is fastest growing segment fueling the growth of Baby Food Market

 


The global Baby Food Market is estimated to be valued at US$ 50.47 Bn in 2023 and is expected to exhibit a CAGR of 5.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:

Baby food products provide balanced nutrition to infants and toddlers and address their daily nutritional needs. These products are available in various forms such as infant formula, baby cereals, prepared baby food, and other baby food.

Market key trends:

One of the key trends witnessed in the baby food market is the launch of organic baby food products. With growing awareness regarding health benefits of organic food among parents, there is a rise in the demand for organic baby food products. Organic baby food refers to food produced without artificial ingredients, pesticides, synthetic fertilizers, irradiation, or sewage sludge. These products are gaining popularity among health-conscious parents as they help provide babies with natural and nutritious food options.

Segment Analysis

The Global Baby Food Market Size is segmented into prepared baby food and dried baby food. Within prepared baby food, milk formula is the largest segment, accounting for over 45% share in 2022. Milk formula provides complete balanced nutrition required for infants. Moreover, growing awareness about importance of breast milk supplementation and convenience of packaged milk formula is driving the growth of this segment.

Key Takeaways

The global baby food market is expected to witness high growth, exhibiting CAGR of 5.5% over the forecast period, due to increasing awareness about baby nutrition and growing number of working women population. The market size for 2023 is US$ 50.47 Bn.

Regional analysis
North America dominates the global baby food market, accounting for over 35% share in 2022. This is attributed to the rising number of working mothers and increasing adoption of bottle feeding in countries like the U.S. and Canada. Asia Pacific is expected to be the fastest growing market, expanding at a CAGR of around 7% during 2023 - 2030. Rapid urbanization and growth in middle class population is fueling the demand for packaged baby food in emerging economies of China and India.

Key players
Key players operating in the baby food market are Nestle S.A., Groupe Danone, Abbott Laboratories, Hain Celestial Group, and Kraft Heinz Company. Nestle leads the global baby food market, owing to its strong brand portfolio and wide distribution network across 190 countries. Danone is another major player, driving growth through continuous innovation in product offerings tailored to regional tastes.

Read More : https://www.rapidwebwire.com/baby-food-market-size-share-analysis-2023-2030/


Comments

Post a Comment

Popular posts from this blog

Macrophage Marker Market Poised to Grow at a Robust Pace Due to Rising Demand in Medical Diagnostics

Image
  The macrophage marker market has witnessed significant growth in recent years owing to the growing applications of macrophage markers in medical diagnostics. Macrophage markers are proteins or cell surface receptors that are expressed by macrophages and are used to identify and study macrophages and their functions. Some of the key macrophage markers include CD14, CD68, CD163, CD206, and LAMP-3. These markers play a vital role in studying the functions of macrophages in various diseases like cancer, inflammatory disorders, and infectious diseases. The global macrophage marker market is estimated to be valued at US$ 295.15 million in 2024 and is expected to exhibit a CAGR of 2.7% over the forecast period of 2024-2030. The growing prevalence of various chronic and infectious diseases and increase in R&D spending for drug discovery are some of the key factors driving the demand for macrophage markers in recent years. Macrophage markers help in evaluating disease progression, drug
Read more

The global Cancer Diagnostics Market is growing at an accelerated pace

Image
  Cancer diagnostics involve various tests and procedures used to detect different types of cancers as early as possible to help improve treatment outcomes. From simple blood tests and imaging scans to biopsies and molecular testing, cancer diagnostics help doctors determine if an individual has cancer, where it is located in the body, if it has spread, and other important information. The growing incidences of various cancers like breast, lung, prostate and colorectal cancer globally have increased the demand for advanced and effective diagnostic procedures. Early detection is critical for cancers to treat them effectively and improve chances of survival. The global Cancer Diagnostics Market is estimated to be valued at US$ 59.1 Bn in 2023 and is expected to exhibit a CAGR of 6.3% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Immunohistochemistry is one of the key diagnostic trends gaining populari
Read more

Growth Accelerated by Rising Demand from Biomedical Research and Clinical Diagnostics

Image
  Chemiluminescence imaging is widely used technique for the detection of biomolecules. The technique offers advantages such as high sensitivity, minimal sample requirement and less incubation time. Chemiluminescence assays find wide application in various research areas such as oncology research, infectious disease research and reproductive health among others. Moreover, clinical diagnostics of conditions like cancer, liver disorders also rely on chemiluminescence technique for detection of biomarkers. Growing incidence of chronic diseases is propelling the demand for clinical diagnostic testing, thus favoring the growth of chemiluminescence imaging market. The global Chemiluminescence Imaging Market is estimated to be valued at US$ 13.2 Bn in 2023 and is expected to exhibit a CAGR of 7.5% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. Market key trends: Rising demand from biomedical research and clinical diagnostics
Read more